Paper
0
Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―
Authors
Hiroaki Kitaoka,Masaki Ieda
Mio Ebato,Ken Kozuma,Morimasa Takayama,Kaoru Tanno,Nobuyuki Komiyama,Yasushi Sakata,Yuichiro Maekawa,Yuichiro Minami,Akiyoshi Ogimoto,Tomofumi Takaya,Satoshi Yasuda,Eisuke Amiya,Yutaka Furukawa,Tetsuya Watanabe,Daigo Hiraya,Hidetaka Miyagoshi,Gen Kinoshita,Alison Reedy,Sheila Hegde,Victoria Florea
+20 authors
,Chisato IzumiJournal
Published
Nov 6, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.